Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells

Although therapeutic effects of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists rosiglitazone and pioglitazone against Cushing's disease have been reported, their effects are still controversial and inconsistent. We therefore examined the effects of a novel PPAR-γ agonist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PPAR Res
Autors principals: Parvin, Rehana, Noro, Erika, Saito-Hakoda, Akiko, Shimada, Hiroki, Suzuki, Susumu, Shimizu, Kyoko, Miyachi, Hiroyuki, Yokoyama, Atsushi, Sugawara, Akira
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937427/
https://ncbi.nlm.nih.gov/pubmed/29849538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5346272
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars